000			03562nam a22005297a 4500
008			211101s20212021 xxu||||| |||| 00| 0 eng d
022			_a1076-0512
040			_aOvid MEDLINE(R)
099			_a34608096
245			_aMerkel Cell Carcinoma: A Bibliometric Analysis of the Top 100 Cited Publications.
251			_aDermatologic Surgery. 48(1):22-27, 2022 01 01.
252			_aDermatol Surg. 48(1):22-27, 2022 01 01.
252			_zDermatol Surg. 2021 Sep 30
253			_aDermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
260			_c2022
260			_fFY2022
265			_saheadofprint
265			_sppublish
266			_d2021-11-01
268			_aDermatologic Surgery. 2021 Sep 30
269			_fFY2022
520			_aBACKGROUND: Bibliometric studies provide a quantitative statistical analysis of the published literature within a field of interest and allow for easy identification of the major contributing authors, funding sources, and publication trends within the field. To date, no bibliometric studies have been performed pertaining to Merkel cell carcinoma (MCC).
520			_aCONCLUSION: Through this bibliometric analysis, researchers can easily identify key publications pertaining to MCC, which may in turn enhance their approach to understanding and practicing evidence-based medicine regarding MCC. Copyright (c) 2021 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.
520			_aMETHODS: Web of science was queried to determine the 100 most frequently cited MCC publications published between the years 1970 and 2019. Articles were listed by title, authors and their affiliated institutions, journal title and type, year of publication, country of origin, funding sources, and citation frequency.
520			_aOBJECTIVE: To identify the 100 most frequently cited articles in MCC through a bibliometric analysis of the literature.
520			_aRESULTS: Among the 100 most frequently cited MCC publications, articles were cited between 67 and 589 times with a mean of 136.3 times. Articles were cited between 2.0 and 98.2 times per year since publication with a mean of 11.3 times per year. 67% of the articles were published in oncology journals; 33% and 10% of the articles in dermatology and surgery journals, respectively. The most represented journal was Cancer (12%). Paul Nghiem was the most frequently identified author (18%). 36% of the top 100 articles were published out of the University of Washington. The most frequent funding agency was the National Institutes of Health (77%).
546			_aEnglish
650			_a*Bibliometrics
650			_a*Carcinoma, Merkel Cell
650			_a*Skin Neoplasms
650			_aCarcinoma, Merkel Cell/di [Diagnosis]
650			_aCarcinoma, Merkel Cell/mo [Mortality]
650			_aCarcinoma, Merkel Cell/th [Therapy]
650			_aEvidence-Based Medicine/mt [Methods]
650			_aHumans
650			_aMedical Oncology/mt [Methods]
650			_aSkin Neoplasms/di [Diagnosis]
650			_aSkin Neoplasms/mo [Mortality]
650			_aSkin Neoplasms/th [Therapy]
651			_aMedStar Washington Hospital Center
656			_aMedical Dermatology Residency
657			_aJournal Article
700			_aRussomanno, Kristen
790			_aDeng M, Pakhchanian H, Raiker R, Russomanno K
856			_uhttps://dx.doi.org/10.1097/DSS.0000000000003251 _zhttps://dx.doi.org/10.1097/DSS.0000000000003251
942			_cART _dArticle
999			_c998 _d998